SUMMARY Total height, sitting height, and subischial leg length were measured in 27 patients (19 girls and eight boys aged 4.3-21-1 years) with congenital adrenal hyperplasia to determine the influence of chronic hyperandrogenaemia on body proportions. Proportions were normal in 24 patients with classical congenital adrenal hyperplasia who had received steroid treatment since birth, but one of three patients with non-classical (late onset) congenital adrenal hyperplasia had a disproportionately large trunk. Eleven patients with classical congenital adrenal hyperplasia had completed growth, of whom seven had height standard deviation (SD) scores for chronological age less than zero, and one had extremely short stature (SD score -3.25). In 13 patients who were still growing, nine had height SD scores for chronological age of less than zero despite having mean (SD) advances in bone age over chronological age of 1-64 (1-68) years. Height SD scores for bone age were less than 0 in all 13 patients, indicating a loss of height despite advanced skeletal maturation.
SUMMARY Total height, sitting height, and subischial leg length were measured in 27 patients (19 girls and eight boys aged 4.3-21-1 years) with congenital adrenal hyperplasia to determine the influence of chronic hyperandrogenaemia on body proportions. Proportions were normal in 24 patients with classical congenital adrenal hyperplasia who had received steroid treatment since birth, but one of three patients with non-classical (late onset) congenital adrenal hyperplasia had a disproportionately large trunk. Eleven patients with classical congenital adrenal hyperplasia had completed growth, of whom seven had height standard deviation (SD) scores for chronological age less than zero, and one had extremely short stature . In 13 patients who were still growing, nine had height SD scores for chronological age of less than zero despite having mean (SD) advances in bone age over chronological age of 1-64 (1-68) (fig 4) . Similar results were obtained when each group was analysed separately. Body proportions were therefore normal in all patients except for one (case 25), who had a disproportionately large trunk (function score +2-10).
Discussion
Congenital adrenal hyperplasia is associated with hyperandrogenaemia during both prenatal and postnatal life. Plasma testosterone and androstenedione concentrations of 22 nmol/l and 216 nmol/l, respectively, (adult reference ranges for men 10-30 and 4-4-10*6 nmolIl, respectively) have been recorded in a female fetus with congenital adrenal hyperplasia of 22 weeks' gestation (unpublished observation). Treatment aims to suppress the adrenal production of excess androgens, thereby allowing normal growth and development. Measurements of concentrations of adrenal steroids in plasma and saliva, in addition to monitoring growth, are important indices of therapeutic control, and treatment aims to keep these within the normal range. ' Patients in group 2 were carefully monitored and treated with adequate doses of glucocorticoids, yet they showed an increase in bone age over chronological age as a result of mild chronic or intermittent hyperandrogenaemia. Similar treatment regimens were used for patients in group 1 who had fused epiphyses at the time of the study. Neither group, however, showed evidence of body disproportion as a result of excessive truncal growth. This was observed in only one girl with untreated late onset congenital adrenal hyperplasia in whom skeletal maturation was extremely advanced; plasma testosterone and androstenedione concentrations were 18 and 70 nmol/l, respectively.
The results of this study suggest that body proportions are usually normal in congenital adrenal hyperplasia despite chronic or intermittent hyperandrogenaemia, except perhaps where severe hyperandrogenaemia has been present in the postnatal period for some considerable time. In keeping with the results of other studies2-5 14 15 final height was below average in patients in group 1 who had completed their growth. Three of the 11 patients were above average height, while the remainder showed varying degrees of shortness. In seven of these patients (not including case 6), height outcome could be judged in comparison with parental heights; five achieved final heights less than the mid parental height and in two cases this was greater than -2SD below the latter.
Height in those still growing (group 2) was suboptimal, particularly when height SD scores were related to bone age. Loss of height was apparently less in boys than in girls (height SD score for chronological age 0*73 (1-28) and -1-36 (0.97), respectively), but boys had a disproportionate advance in bone age ((bone age-chronological age); for boys 2 71 (2.27), and girls 0-80 (0.98)). This height advantage disappeared when height SD score was expressed for bone age (fig 1) 
